NewsRoom Articles

ThursdaySep 03, 2026 9:45 am

Frontieras North America Inc.’s Leaders Bring Core Expertise, Background as Company Moves Toward Commercial Execution

For companies seeking to lead the way forward in industrial technology, leadership experience can become a strategic asset equal in importance to the underlying technology itself. Cofounder, CEO and chair Matthew McKean’s professional background spans sales, management, finance and entrepreneurship. Cofounder and CTO Joseph Witherspoon’s career has been centered on engineering, process design and industrial project execution. The success of large-scale industrial and energy technologies often depends on more than the technology itself. Companies must also possess the leadership, operational expertise and execution capabilities necessary to move projects from development into commercial operation. Frontieras North America is pursuing that path in the…

WednesdaySep 02, 2026 10:00 am

Boosting Thymus Health Could Improve Treatment Outcomes in Lung Cancer

Protecting a long-overlooked immune organ during cancer treatment may meaningfully improve outcomes for lung cancer patients, according to new research from Mass General Brigham. The study, published in Annals of Oncology, found that unintended radiation exposure to the thymus during lung cancer treatment was linked to worse clinical results. These findings suggest that doctors may eventually need to factor thymus protection into how radiation therapy is planned. This small gland, sitting just behind the breastbone, is where immune cells called T cells mature and learn to spot threats such as infections and cancer. For years, doctors assumed the gland stopped mattering much once someone reached adulthood.…

MondayAug 31, 2026 10:00 am

Financing Gap Threatens Investment in Clean Energy

A financing gap is putting clean energy investment at risk, even as capital floods into the sector at record levels. Capital in private markets is increasingly split between two extremes. Plentiful venture funding chases early-stage startups on one side. At the same time, a deep reservoir of pension- and insurance-style money seeks out established assets with predictable earnings and long track records. There’s a widening shortfall between those two extremes, and it is squeezing exactly the businesses that the next stage of the transition depends on. Companies land in that middle zone once they've moved past pilot projects and begun constructing and operating large facilities that…

WednesdayAug 26, 2026 10:00 am

Krypton Gas Could Increasingly Be Used in Quantum Computing

Krypton gas is emerging as an unlikely fix for one of quantum computing's manufacturing headaches. Cornell researchers have found that replacing argon with krypton gas during a key fabrication step allows tantalum, a metal prized for superconducting devices, to be deposited at much lower temperatures. That single change could remove a major obstacle between tantalum's promise in the lab and its practical use in chip factories, and bring us closer to developing functional quantum computers. Bonding tantalum to a silicon wafer has generally required heat well above 400°C (about 752°F), which is more than many pieces of chip-fabrication equipment are designed to handle. The new method brings that figure down…

MondayAug 24, 2026 10:30 am

Frontieras North America Inc. Advances a Low-Sulfur Industrial Carbon That Heavy Industry Is Already Looking For

The challenge for steel and other heavy industries is not finding carbon; it is finding carbon that performs reliably without introducing sulfur into the process. FASCarbon(TM) is the solid carbon output of Frontieras’s FASForm(TM) process, a continuous solid carbon fractionation system that thermally cracks coal without combustion. FASCarbon’s low sulfur content makes it a direct substitute for higher-grade, more expensive carbon inputs in steelmaking and industrial heating applications. Coal has always been valued for what it produces when burned. Frontieras North America has built a business around what it produces when it isn’t burned. The company’s FASForm(TM) process fractionates coal into its molecular…

MondayAug 24, 2026 10:00 am

New T Cell Therapy Could Transform Glioblastoma Care

Recurrent glioblastoma leaves patients with almost no effective treatments to fall back on. Standard therapies typically combine surgery with chemotherapy, but the disease usually comes back in a harsher, harder-to-treat form. Median survival after recurrence is less than a year. A new Phase I trial published August 6 in the journal Nature Medicine suggests an experimental immunotherapy may finally offer these patients another option. The treatment relies on CAR-T cell therapy, an approach that re-engineers a patient's own immune cells to hunt down cancer. Researchers trained the modified cells, known as CAR-T cells, to target B7-H3, a protein found on the surface of most glioblastomas but largely absent from healthy tissue. Scientists…

FridayAug 21, 2026 11:15 am

Frontieras North America Inc. Positions Domestic Coal as America’s Answer to Energy Supply Disruption

The United States sits on a significant coal resource base. FASForm produces six commercial outputs from a single coal input: diesel, naphtha, jet fuel, ammonium sulfate fertilizer, sulfuric acid and FASCarbon(TM). Frontieras is moving this technology from development into construction. The Strait of Hormuz closure that began in late February 2026 removed more than 11 million barrels of Middle Eastern crude per day from global markets and sent Brent crude from roughly $62 a barrel in December 2025 to more than $117 by April 2026. Diesel and jet fuel wholesale prices are forecast to rise more than 60% in 2026…

WednesdayAug 19, 2026 10:00 am

Mathematical Study Offers Possible Fix to Melanoma Therapy Mystery

A mathematical study published in the journal Mathematical Business may have just offered a possible solution to a long-standing mystery in melanoma treatment. This is a skin cancer that starts in melanocytes, the cells responsible for determining skin color, and it typically occurs due to exposure to ultraviolet (UV) light rays from the sun and tanning beds. Although the condition is very treatable when discovered early, one mystery regarding melanoma therapy has stumped researchers for years. Studies have indicated that periodically halting the delivery of specific targeted drugs can restrain drug-resistant melanoma cells. However, experiments with intermittent dosing have shown…

MondayAug 17, 2026 10:00 am

China Releases Plan to Modernize Coal Industry in 5 Years

Beijing has revealed a plan to modernize the country’s coal industry over the next 5 years. Published by the National Energy Administration and the National Development and Reform Commission, the plan will see China speed up the upgrading and optimization of the domestic coal industry during the 15th Five-Year Plan period. This is a development blueprint approved in March 2026 as a framework for Chinese economic and social growth for the rest of the decade, culminating in 2030 when coal consumption in China is predicted to peak. As Chinese energy demand continues to rise, and China installs record levels of new renewable capacity every year,…

WednesdayAug 12, 2026 10:00 am

Researchers Use AI to Create Viruses with Possible Therapeutic Applications

A multi-institutional research team has published a paper that has increased hopes about the role of artificial intelligence in advancing medicine, but also raised questions about the dangers represented by cutting-edge technologies like AI. In a paper published in the journal Science, researchers from Harvard, the Broad Institute of MIT and Stanford University outlined how they used artificial intelligence alongside a bacteria-infecting virus to generate thousands of new virus genomes. According to the researchers, they were left with 16 ‘viable’ viruses after chemically synthesizing most of the new genomes and testing them in sterile lab conditions. Surprisingly, the researchers found that some of the synthetic viruses killed…

Spotlighting undiscovered companies with enormous upside potential.

Contact us: (512) 354-7000